0001127602-13-034708.txt : 20131216 0001127602-13-034708.hdr.sgml : 20131216 20131216163007 ACCESSION NUMBER: 0001127602-13-034708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131212 FILED AS OF DATE: 20131216 DATE AS OF CHANGE: 20131216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO CO CENTRAL INDEX KEY: 0000820096 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382799573 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 BUSINESS PHONE: 2696738451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPA JOSEPH C CENTRAL INDEX KEY: 0001242215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09689 FILM NUMBER: 131279239 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS INC STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-12-12 0000820096 PERRIGO CO PRGO 0001242215 PAPA JOSEPH C C/O PERRIGO COMPANY 515 EASTERN AVENUE ALLEGAN MI 49010 1 1 1 President and CEO Chairman Common Stock 2013-12-12 4 M 0 3963 35.85 A 120618 D Common Stock 2013-12-12 4 S 0 3963 150.2179 D 116655 D Common Stock 2013-12-12 4 M 0 2186 30.06 A 118841 D Common Stock 2013-12-12 4 S 0 2186 150.4851 D 116655 D Common Stock 2013-12-12 4 M 0 8851 58.82 A 125506 D Common Stock 2013-12-12 4 S 0 1164 149.4278 D 124342 D Common Stock 2013-12-12 4 S 0 7687 150.073 D 116655 D Common Stock 2013-12-09 5 G 0 E 20000 0 D 96655 D Employee Stock Option Right to Buy 35.85 2013-12-12 4 M 0 3963 0 D 2018-08-25 Common Stock 3963 0 D Employee Stock Option Right to Buy 30.06 2013-12-12 4 M 0 2186 0 D 2010-08-25 2019-08-25 Common Stock 2186 0 D Employee Stock Option Right to Buy 58.82 2013-12-12 4 M 0 8851 0 D 2020-08-19 Common Stock 8851 30183 D This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 11, 2013. This 10b5-1 sales plan will expire on the close of business November 11, 2014. The price in column 4 is a weighted average. The prices actually received ranged from $149.85 to $150.61. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. The price in column 4 is a weighted average. The prices actually received ranged from $150.28 to $150.68. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. The price in column 4 is a weighted average. The prices actually received ranged from $149.37 to $149.465. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. The price in column 4 is a weighted average. The prices actually received ranged from $149.48 to $150.47. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Exercisable in 3 equal annual installments beginning 8/25/09. Exercisable in 3 equal annual installments beginning 8/19/11. /s/ Penny Bursma, Attorney-in-fact for Joseph C. Papa 2013-12-16